Jia Conway, DNP, FNP-BC, AOCNP, NP-C

Most Recent Articles by Jia Conway, DNP, FNP-BC, AOCNP, NP-C

Handling Closed System Device-Incompatible Chemotherapy Agents

Handling Closed System Device-Incompatible Chemotherapy Agents

By

How can accidental exposure/leaks when handling chemotherapy drugs that incompatible with the closed system device (CSD) be prevented?

Port functionality with irinotecan administration

Port functionality with irinotecan administration

By

Subcutaneous power ports seem to rarely function properly when administering irinotecan but function properly when the regimen changes. Is there an explanation for why this happens?

Standard IV administration of KCL

Standard IV administration of KCL

By

Is there a standard process for administering KCL through an IV?

Efficacy of Cathflo at suggested volume

Efficacy of Cathflo at suggested volume

By

Given reservoir volume and catheter length, 2.2 mL of Cathflo does not seem to be enough volume to reach the tip, thus the sheath/clot. Are there any reports of using larger volumes?

Personal protective equipment (PPE) guidelines for handling monoclonal antibodies (MABs)

Personal protective equipment (PPE) guidelines for handling monoclonal antibodies (MABs)

By

Is there a new consensus about wearing personal protective equipment (PPE) when handling monoclonal antibodies (MABs) for infusion?

More Articles by Jia Conway, DNP, FNP-BC, AOCNP, NP-C

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs